Knee Osteoarthritis
Conditions
Interventions
A experimental group:Cocktail injection therapy with ropivacaine injection 200mg+ketorolac tromethamine injection 30mg+0.9% sodium chloride injection 20ml
B experimental group:Cocktail injection therapy with ropivacaine injection 200mg+ketorolac tromethamine injection 30mg+0.9% sodium chloride injection 40ml
Sponsors
Shengjing Hospital Affiliated to China Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients who underwent artificial total knee arthroplasty due to unilateral knee osteoarthritis in the Spinal Joint Surgery Department of Shengjing Hospital Affiliated to China Medical University from January 1, 2024 to August 31, 2026; Patients with complete preoperative and postoperative clinical and imaging data and signed informed consent forms
Exclusion criteria
Exclusion criteria: Patients who are allergic to the drugs used in this study; Patients with severe knee joint deformity (valgus or varus deformity = 30 °); Patients with a history of knee joint surgery or infection; Patients who have been using opioid drugs for a long time; Patients with severe organ dysfunction who are unable to tolerate surgery; Patients with abnormal coagulation function; Cancer patients; Mental illness patients; Patients who refuse to sign informed consent forms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Circumferential diameter of the knee joint on the surgical side;Pain rebound time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Knee joint range of motion (ROM);VAS scores;AKS scores; | — |
Countries
China
Contacts
Public ContactYe Tian
Shengjing Hospital Affiliated to China Medical University
Outcome results
None listed